Loading company…
VAXDIGM develops vaccines and protein production technologies using microbial systems.
Founded in 2021 by Seung-Hoo Kim and based in Seoul, VAXDIGM researches and develops vaccines, including improved and future vaccines such as COVID-19 and flu combination vaccines. Its technology uses microorganisms to produce vaccine antigens. In May 2026, the company raised KRW 1.5 billion from the Ministry of SMEs and Startups, with returning investor Korea Tech Incubator for Startup, through the Deep-Tech TIPS program. It plans to use the funding to validate and commercialize its protein production platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in